Diffuse neonatal hemangiomatosis

From WikiMD's WELLNESSPEDIA


Diffuse neonatal hemangiomatosis
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Multiple hemangiomas on skin and internal organs
Complications Heart failure, anemia, thrombocytopenia
Onset Neonatal period
Duration Varies
Types N/A
Causes Unknown
Risks
Diagnosis Clinical examination, imaging studies
Differential diagnosis Infantile hemangioma, Kasabach-Merritt syndrome
Prevention N/A
Treatment Corticosteroids, beta blockers, interferon
Medication
Prognosis Variable, can be life-threatening
Frequency Rare
Deaths N/A


Diffuse Neonatal Hemangiomatosis is a rare, severe disorder characterized by multiple hemangiomas. Hemangiomas are noncancerous (benign) growths consisting of a mass of blood vessels. They are the most common benign blood vessel (vascular) abnormalities of infancy.

Signs and Symptoms[edit]

The signs and symptoms of diffuse neonatal hemangiomatosis may vary but can include:

  • Multiple, small, red or reddish-purple skin lesions on the skin
  • Lesions may also be present on internal organs such as the liver, lung, brain, and gastrointestinal tract
  • Potential complications can include heart failure due to high-output cardiac failure, bleeding from lesions within the gastrointestinal tract, and/or other serious complications

Causes[edit]

The exact cause of diffuse neonatal hemangiomatosis is currently unknown. However, it is thought to occur randomly for no apparent reason (sporadically).

Diagnosis[edit]

Diagnosis of diffuse neonatal hemangiomatosis is made based upon a thorough clinical evaluation, a detailed patient history, and specialized tests such as ultrasound imaging, magnetic resonance imaging (MRI), and/or other tests.

Treatment[edit]

The treatment of diffuse neonatal hemangiomatosis is directed toward the specific symptoms that are apparent in each individual. Treatment may include corticosteroid therapy or interferon therapy. In severe cases, surgical removal of individual hemangiomas may be necessary.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.